CLINICAL_TRIALS trial_result · 2021-09-05

Clinical Trial Update: This Study Will Investigate the Efficacy and Safety of A4250 in Children With PFIC Types 1 or 2 [Phase 3]

Phase 3 trial of A4250 in children with progressive familial intrahepatic cholestasis types 1 and 2 has been completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Albireo | Conditions: PFIC1, PFIC2 | Phase 3 | Status: COMPLETED | Results posted: 2021-09-05